Dr. Michael E. Manning, MD
Allergy & Immunology (Allergy & Immunology Physician)
7514 E Monterey Way, Suite 1
Scottsdale, AZ 85251
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at Houston (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,074
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: University of Texas Medical School at Houston
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy & Immunology Physician primary
AZ license 17209
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Honor Health John C. Lincoln Medical Center Phoenix, AZ
- Yavapai Regional Medical Center Prescott, AZ
- Banner PAyson Medical Center Payson, AZ
Medical groups
- Allergy, Asthma and Immunology Associates LTD (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,074
- Services billed
- 88,342
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 35,840 | 70 |
| Injection, omalizumab, 5 mg | 33,525 | 84 |
| Injection, immune globulin (bivigam), 500 mg | 19,610 | 58 |
| Injection, tezepelumab-ekko, 1 mg | 13,440 | 18 |
| Injection, mepolizumab, 1 mg | 10,200 | 16 |
| Test for allergy using allergenic extract | 4,883 | 79 |
| Professional service for preparation and provision of 1 or more antigens | 4,645 | 344 |
| Professional service for multiple injections of allergen | 4,245 | 463 |
| Injection of drug or substance under skin or into muscle | 1,441 | 139 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 1,363 | 81 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Montelukast Sodium Other prescribers in Scottsdale, AZ | 221 |
| Ipratropium Bromide Other prescribers in Scottsdale, AZ | 166 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Scottsdale, AZ | 159 |
| Prednisone Other prescribers in Scottsdale, AZ | 111 |
| Azelastine Hcl Other prescribers in Scottsdale, AZ | 106 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Scottsdale, AZ | 84 |
| Fluticasone Propionate Other prescribers in Scottsdale, AZ | 80 |
| Takhzyro (lanadelumab-flyo) | 71 |
| Azithromycin Other prescribers in Scottsdale, AZ | 66 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Scottsdale, AZ | 55 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 24 companies reported 304 payments worth $183,947 in total to this clinician.
| Csl Behring | $41,134 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $31,543 |
| Novartis Pharmaceuticals Corporation | $25,410 |
| Pharming Healthcare, Inc. | $17,093 |
| Ionis Pharmaceuticals, Inc. | $16,272 |
| Biocryst US Sales Co., LLC | $10,827 |
| Sanofi US Services Inc. | $9,546 |
| AstraZeneca Pharmaceuticals LP | $8,384 |
| Compensation for services other than consulting (speaking, faculty) | $113,991 |
|---|---|
| Consulting Fee | $50,348 |
| Travel and Lodging | $10,911 |
| Food and Beverage | $5,998 |
| Honoraria | $2,660 |
| Education | $38.82 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $8,750 |
| Takeda Pharmaceuticals U.S.A., Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) TAKHZYRO · GENETIC DISEASE | $8,223 |
| Takeda Pharmaceuticals U.S.A., Inc. Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) TAKHZYRO · GENETIC DISEASE | $8,223 |
| Sanofi US Services Inc. Sep 9, 2025 | Compensation for services other than consulting (speaking, faculty) AYVAKIT · Gastroenterology | $6,983 |
| Pharming Healthcare, Inc. Mar 26, 2025 | Consulting Fee RUCONEST · BIOLOGIC | $6,750 |
| Biocryst US Sales Co., LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) ORLADEYO · Immunology | $6,555 |
| Csl Behring Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $5,100 |
| Csl Behring Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $5,100 |
| Csl Behring Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $5,033 |
| Novartis Pharmaceuticals Corporation Sep 12, 2025 | Consulting Fee | $4,800 |
All 102 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) TAKHZYRO · GENETIC DISEASE | $4,648 |
| Takeda Pharmaceuticals U.S.A., Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) TAKHZYRO · GENETIC DISEASE | $1,788 |
| Biocryst Pharmaceuticals, Inc. Dec 29, 2025 | Consulting Fee ORLADEYO · Immunology | $3,850 |
| Genentech USA, Inc. Dec 22, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $940 |
| AstraZeneca Pharmaceuticals LP Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| Csl Behring Dec 11, 2025 | Travel and Lodging Andembry · Hematology · travel to Oakbrook, IL · in-kind | $416 |
| Genentech USA, Inc. Dec 9, 2025 | Travel and Lodging Xolair · Immunology · travel to El Paso, TX · in-kind | $309 |
| Genentech USA, Inc. Dec 9, 2025 | Travel and Lodging Xolair · Immunology · travel to El Paso, TX · in-kind | $196 |
| Genentech USA, Inc. Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $940 |
| Genentech USA, Inc. Nov 21, 2025 | Travel and Lodging Xolair · Immunology · travel to El Paso, TX · in-kind | $75.00 |
| Csl Behring Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $3,236 |
| Csl Behring Nov 20, 2025 | Consulting Fee Andembry · Hematology | $2,517 |
| Pharming Healthcare, Inc. Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) RUCONEST · BIOLOGIC | $3,750 |
| Ionis Pharmaceuticals, Inc. Nov 9, 2025 | Consulting Fee DAWNZERA · PULMONOLOGY & IMMUNOLOGY | $4,170 |
| Novartis Pharmaceuticals Corporation Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) Rhapsido · Immunology | $4,000 |
| Biocryst Pharmaceuticals, Inc. Nov 5, 2025 | Travel and Lodging ORLADEYO · Immunology · travel to Orlando, FL · in-kind | $366 |
| Genzyme Corporation Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,932 |
| Biocryst US Sales Co., LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) ORLADEYO · Immunology | $6,555 |
| Biocryst US Sales Co., LLC Oct 23, 2025 | Travel and Lodging ORLADEYO · Immunology · travel to Fresno, CA · in-kind | $465 |
| Biocryst US Sales Co., LLC Oct 23, 2025 | Travel and Lodging ORLADEYO · Immunology · travel to Fresno, CA · in-kind | $227 |
| Biocryst US Sales Co., LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) ORLADEYO · Immunology | $95.00 |
| Csl Behring Oct 12, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $741 |
| Novartis Pharmaceuticals Corporation Oct 10, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX · in-kind | $196 |
| Ionis Pharmaceuticals, Inc. Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) DAWNZERA · PULMONOLOGY & IMMUNOLOGY | $2,780 |
| Takeda Pharmaceuticals U.S.A., Inc. Oct 6, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to DOTHAN, AL · in-kind | $448 |
| Takeda Pharmaceuticals U.S.A., Inc. Oct 6, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to DOTHAN, AL · in-kind | $62.00 |
| Ionis Pharmaceuticals, Inc. Sep 30, 2025 | Compensation for services other than consulting (speaking, faculty) DAWNZERA · PULMONOLOGY & IMMUNOLOGY | $4,170 |
| Ionis Pharmaceuticals, Inc. Sep 29, 2025 | Compensation for services other than consulting (speaking, faculty) DAWNZERA · PULMONOLOGY & IMMUNOLOGY | $4,170 |
| Ionis Pharmaceuticals, Inc. Sep 19, 2025 | Travel and Lodging DAWNZERA · PULMONOLOGY & IMMUNOLOGY · travel to CARLSBAD, CA · in-kind | $272 |
| Ionis Pharmaceuticals, Inc. Sep 19, 2025 | Travel and Lodging DAWNZERA · PULMONOLOGY & IMMUNOLOGY · travel to CARLSBAD, CA · in-kind | $257 |
| Csl Behring Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $2,700 |
| Csl Behring Sep 18, 2025 | Travel and Lodging Andembry · Hematology · travel to El Paso, TX | $68.80 |
| Sanofi US Services Inc. Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) AYVAKIT · Gastroenterology | $1,330 |
| Novartis Pharmaceuticals Corporation Sep 12, 2025 | Consulting Fee | $4,800 |
| Novartis Pharmaceuticals Corporation Sep 12, 2025 | Travel and Lodging travel to TUCSON, AZ | $851 |
| Sanofi US Services Inc. Sep 9, 2025 | Compensation for services other than consulting (speaking, faculty) AYVAKIT · Gastroenterology | $6,983 |
| Sanofi US Services Inc. Sep 9, 2025 | Travel and Lodging AYVAKIT · Gastroenterology · travel to Birmingham, AL · in-kind | $842 |
| Sanofi US Services Inc. Sep 9, 2025 | Travel and Lodging AYVAKIT · Gastroenterology · travel to Birmingham, AL · in-kind | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) TAKHZYRO · GENETIC DISEASE | $8,223 |
| Csl Behring Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $2,700 |
| Csl Behring Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $5,033 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 19, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to DOTHAN, AL · in-kind | $842 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 19, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to DOTHAN, AL · in-kind | $507 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 19, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to DOTHAN, AL · in-kind | $173 |
| Csl Behring Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $5,100 |
| Csl Behring Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $5,100 |
| GlaxoSmithKline, LLC. Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $2,600 |
| Csl Behring Aug 8, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $1,079 |
| Csl Behring Aug 7, 2025 | Travel and Lodging Andembry · Hematology · travel to El Paso, TX · in-kind | $458 |
| Csl Behring Aug 7, 2025 | Travel and Lodging Andembry · Hematology · travel to El Paso, TX · in-kind | $254 |
| Csl Behring Aug 5, 2025 | Travel and Lodging Andembry · Hematology · travel to Boise, ID · in-kind | $443 |
| AstraZeneca Pharmaceuticals LP Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| Csl Behring Aug 5, 2025 | Travel and Lodging Andembry · Hematology · travel to Boise, ID · in-kind | $209 |
| Pharming Healthcare, Inc. Jul 30, 2025 | Consulting Fee RUCONEST · BIOLOGIC | $3,750 |
| GlaxoSmithKline, LLC. Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $2,600 |
| Regeneron Healthcare Solutions, Inc. Jul 18, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $11.26 |
| Csl Behring Jul 11, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $900 |
| Csl Behring Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology | $899 |
| Novartis Pharmaceuticals Corporation Jul 10, 2025 | Consulting Fee | $675 |
| Adma Biomanufacturing LLC Jul 8, 2025 | Consulting Fee | $6.39 |
| Novartis Pharmaceuticals Corporation Jun 26, 2025 | Consulting Fee | $675 |
| Adma Biomanufacturing LLC Jun 19, 2025 | Consulting Fee | $6.43 |
| Csl Behring Jun 6, 2025 | Consulting Fee Andembry · Hematology | $1,438 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $800 |
| Csl Behring May 29, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $344 |
| AstraZeneca Pharmaceuticals LP May 21, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| Csl Behring May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $2,032 |
| Csl Behring May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $1,313 |
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Consulting Fee | $4,290 |
| Pharming Healthcare, Inc. May 9, 2025 | Consulting Fee RUCONEST · BIOLOGIC | $2,250 |
| AstraZeneca Pharmaceuticals LP May 5, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $8,750 |
| Blueprint Medicines Corporation May 2, 2025 | Honoraria AYVAKIT · Oncology / Rare Diseases | $1,330 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ | $200 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to Whippany, NJ · in-kind | $171 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $88.00 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Travel and Lodging travel to Whippany, NJ · in-kind | $191 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Education in-kind | $19.31 |
| AstraZeneca Pharmaceuticals LP Apr 30, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Phoenix, AZ · in-kind Company’s descriptionSpeaker Expenses | $15.40 |
| Biocryst US Sales Co., LLC Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) ORLADEYO · Immunology | $690 |
| Csl Behring Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $571 |
| AstraZeneca Pharmaceuticals LP Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $2,350 |
| Blueprint Medicines Corporation Apr 24, 2025 | Honoraria AYVAKIT · Oncology / Rare Diseases | $1,330 |
| AstraZeneca Pharmaceuticals LP Apr 21, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to San Tan Valley, AZ · in-kind Company’s descriptionSpeaker Expenses | $25.20 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,999 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,635 |
| Novartis Pharmaceuticals Corporation Apr 4, 2025 | Consulting Fee | $4,050 |
| Genzyme Corporation Apr 1, 2025 | Education DUPIXENT · Immunology · in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $8.25 |
| Pharming Healthcare, Inc. Mar 26, 2025 | Consulting Fee RUCONEST · BIOLOGIC | $6,750 |
| Pharming Healthcare, Inc. Mar 26, 2025 | Travel and Lodging RUCONEST · BIOLOGIC · travel to SCOTTSDALE, AZ · in-kind | $343 |
| Csl Behring Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $1,223 |
| Csl Behring Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) Andembry · Hematology · in-kind | $1,223 |
| AstraZeneca Pharmaceuticals LP Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $2,800 |
| Biocryst US Sales Co., LLC Mar 2, 2025 | Consulting Fee ORLADEYO · Immunology | $2,364 |
| Adma Biomanufacturing LLC Feb 25, 2025 | Consulting Fee | $6.64 |
| Takeda Pharmaceuticals U.S.A., Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) TAKHZYRO · GENETIC DISEASE | $8,223 |
| Takeda Pharmaceuticals U.S.A., Inc. Feb 21, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to CEDAR RAPIDS, IA · in-kind | $88.00 |
| Takeda Pharmaceuticals U.S.A., Inc. Feb 21, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to CEDAR RAPIDS, IA · in-kind | $16.10 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Feb 6, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Chandler, AZ · in-kind Company’s descriptionSpeaker Expenses | $39.20 |
| Takeda Pharmaceuticals U.S.A., Inc. Jan 22, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to CEDAR RAPIDS, IA · in-kind | $997 |
| Takeda Pharmaceuticals U.S.A., Inc. Jan 22, 2025 | Travel and Lodging TAKHZYRO · GENETIC DISEASE · travel to CEDAR RAPIDS, IA · in-kind | $512 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 11 industry-funded studies in 2025, from 6 companies. The companies reported $71,701 in research payments for these studies, mostly to the institutions running them.
- Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma
Sanofi US Services Inc. · Completed · NCT06102005 - An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)
Csl Behring · Completed · NCT07076446 - Study name not reported
Ionis Pharmaceuticals, Inc. - Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT04959448 - A Three-year, Multi-center, Double-blind, Extension Study to Evaluate the Long-term Safety and Efficacy of Ligelizumab in Patients Who Completed Ligelizumab's Phase III Studies in Food Allergy
Novartis Pharmaceuticals Corporation - Registry of Asthma Patients Initiating DUPIXENT®
Regeneron Pharmaceuticals, Inc. · Completed · NCT04287621 - A 52-week, randomised, double-blind, double-dummy, parallel group, mul
GlaxoSmithKline, LLC. - A 52-week multicenter, randomized, double-blind, placebo-controlled study to assess efficacy and safety of remibrutinib (LOU064) in adult and adolescent participants with IgE-mediated food allergy.
Novartis Pharmaceuticals Corporation - A phase 3, 52-week, randomized, double-blind, placebo-controlled, para
GlaxoSmithKline, LLC. - A phase 3, 24-week, randomized, double-blind, parallel-group bayesian
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.